EUVIMEDEUVIMED entdecken
Crossref

Pancreas patch grafting to treat type 1 diabetes

Xianwen Yi, Youmei Xie, David A Gerber

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.149200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Xianwen Yi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: xyi2000@med.unc.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Experimental, Insulin-Secreting Cells. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stem/progenitor cell therapy is a promising treatment option for patients with type 1 diabetes (T1D) a disease characterized by autoimmune destruction of pancreatic β cells. Actively injecting cells into an organ is one option for cell delivery, but in the pancreas, this contributes to acute inflammation and pancreatitis. We employed a patch grafting approach to transplant biliary tree stem cells/progenitor cells (BTSC) onto the surface of the pancreas in diabetic mice. The cells engraft and differentiate into β-like cells reversing hyperglycemia during a four-month period of observation. In addition, C-peptide and insulin gradually increase in blood circulation without detectable adverse effects during this period. Moreover, the patch graft transplant promoted the proliferation and differentiation of pancreatic β-like cells with co-expression of the β cell biomarker. CONCLUSION: BTSC transplantation can effectively attenuate T1D over a four-month period that is vital important for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalInsulin-Secreting CellsHumansMiceAnimalsPancreasInsulinCell Differentiation

Stichwörter der Autor:innen

Biliary tree progenitor cellsCell therapiesDiabetic mouse modelPancreasType I diabetes

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: xyi2000@med.unc.edu.
  • Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: xiey@neurology.unc.edu.
  • Department of Surgery, University of North Carolina, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: david_gerber@med.u…

Zitieren

APA

Yi, X., Xie, Y., & Gerber, D. A. (2023). Pancreas patch grafting to treat type 1 diabetes. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.149200

Vancouver

Yi X, Xie Y, Gerber DA. Pancreas patch grafting to treat type 1 diabetes. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.149200

BibTeX
@article{Yi2023,
  author = {Yi, Xianwen and Xie, Youmei and Gerber, David A},
  title = {Pancreas patch grafting to treat type 1 diabetes},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.149200}
}
Kostenlos starten →